Duke Street Bio Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.dukesb.com
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
Phase 1
Recruiting
- Conditions
- Advanced Malignancies With Homologous Recombination Deficiency (HRD) (Breast, Ovarian, mCRPC, Brain Metastases)
- Interventions
- First Posted Date
- 2024-06-14
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Duke Street Bio Ltd
- Target Recruit Count
- 90
- Registration Number
- NCT06458712
- Locations
- 🇪🇸
Hospital Universitario Reina SofÃa, Cordoba, Spain
🇪🇸Hospital 12 de Octubre, Madrid, Spain
🇪🇸Hospital Universitari Vall d'Hebron, Barcelona, Spain
© Copyright 2025. All Rights Reserved by MedPath